Myeloma Minute: The Search for Myeloma Cure is Never Easy

In the News: The Search to Achieve a Cure Is Never Easy

The US Food and Drug Administration (FDA) suspended three clinical trials of Keytruda (pembrolizumab) in combination with other drugs for multiple myeloma after more patients receiving the drug died than those receiving other treatments. This unfortunate development, writes IMF Chairman Dr. Brian Durie in his blog this week, indicates that combination-drug treatment of myeloma needs to be approached with caution. Read Dr. Durie’s blog.

Coming Soon: Myeloma Updates 2017 Webinar: Best of ASCO/EHA/IMWG - July 13th, 2017 

On Thursday, July 13th, 2017 at 4:00 PM PT / 7:00 PM ET, Dr. Brian Durie will explain the new and exciting current trends in myeloma treatment and research during a Myeloma Updates 2017 webinar. This webinar will feature updates from the three major medical meetings held in June 2017 – the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA), and the International Myeloma Working Group Summit (IMWG). Register for FREE now for this webinar that includes a Q&A session


Save the Date: The IMF's 11th Annual Comedy Celebration - Saturday, November 4th, 2017

The IMF’s 11th Annual Comedy Celebration will be held on Saturday, November 4th, 2017 in Los Angeles, CA.  Ray Romano will host a cast of stellar comedians and performers in raising funds for the Peter Boyle Research Fund supporting the IMF’s groundbreaking Black Swan Research Initiative®. This year, we’re excited to announce that members from around the world will be able to participate remotely, as the evening’s silent auction will take place ONLINE simultaneously! To register for the online auction, to receive updates from the event, or to buy tickets, journal ads, or sponsorships, visit the event site at


Watch This Video on New Agents' Impact on Myeloma Frontline Therapy

During the International Myeloma Working Group annual meeting in Madrid, Spain, leading myeloma experts discussed six topline questions in the field of myeloma. Here is one of the questions from that meeting: How will new agents impact frontline therapy? View more IMWG videos.

Myeloma Canada Discusses Canadians with Myeloma and Their Access to Therapies

In this press release from Myeloma Canada, the organization addresses how Health Canada approved three new drugs for the treatment of myeloma: Kyprolis® (carfilzomib), Darzalex® (daratumumab), and Ninlaro® (ixazomib), yet the pan-Canadian Oncology Drug Review (pCODR) has met with stumbling blocks in delivering these therapies to Canadian multiple myeloma patients.


Donate to the IMF by Shopping on Prime Day

Did you know Amazon's third-annual Prime Day is on Tuesday, July 11th? It will feature more than 100,000 deals exclusively for Prime members, making it one of the biggest shopping days of the year. Don’t forget to shop at, and Amazon will donate to International Myeloma Foundation. Remember - it all adds up!  And get yourself something fantastic at the same time.

Can myeloma cells be detected in the blood instead of the bone marrow? 

In this video, Dr. Brian Durie sheds light on advances in testing for myeloma cells in the blood.



We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Pharmaceuticals, and Takeda Oncology



Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.